26 July 2012 - Boehringer Ingelheim, a pharmaceutical company, and Eli Lilly and Company (NYSE: LLY), a corporation that is developing a growing portfolio of pharmaceutical products, have announced today that that they have received marketing authorisation from the European Commission for Jentadueto...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up